These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15192060)

  • 21. [Contraception in women with diabetes mellitus].
    Nikolov A; Dimitrov A; Kolarov G; Todarova K; Mekhandzhiev Ts
    Akush Ginekol (Sofiia); 2005; 44(5):47-52. PubMed ID: 16313055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of oral contraceptives on risk of cervical cancer.
    Vanakankovit N; Taneepanichskul S
    J Med Assoc Thai; 2008 Jan; 91(1):7-12. PubMed ID: 18386537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ethinylestradiol + norelgestromin: new preparation. Transdermal contraception: no tangible progress.
    Prescrire Int; 2004 Aug; 13(72):123-6. PubMed ID: 15532134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast and cervical cancer in indigenous women-overcoming barriers to early detection.
    Reath J; Carey M
    Aust Fam Physician; 2008 Mar; 37(3):178-82. PubMed ID: 18345371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
    Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
    J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Awareness of breast and cervical cancer risk factors and screening behaviours among nurses in rural region of Turkey.
    Yaren A; Ozkilinc G; Guler A; Oztop I
    Eur J Cancer Care (Engl); 2008 May; 17(3):278-84. PubMed ID: 18419631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Switching hormonal contraceptives to a chlormadinone acetate-containing oral contraceptive. The Contraceptive Switch Study.
    Schramm G; Heckes B
    Contraception; 2007 Aug; 76(2):84-90. PubMed ID: 17656175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of cancer with combined oral contraceptive use among Iranian women.
    Vaisy A; Lotfinejad S; Zhian F
    Asian Pac J Cancer Prev; 2014; 15(14):5517-22. PubMed ID: 25081657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined hormonal contraception and venous thromboembolism.
    Martínez F; Avecilla A
    Eur J Contracept Reprod Health Care; 2007 Jun; 12(2):97-106. PubMed ID: 17559006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Challenges in providing breast and cervical cancer screening services to Vietnamese Canadian women: the healthcare providers' perspective.
    Donnelly TT
    Nurs Inq; 2008 Jun; 15(2):158-68. PubMed ID: 18476858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical breast and pelvic examination requirements for hormonal contraception: Current practice vs evidence.
    Stewart FH; Harper CC; Ellertson CE; Grimes DA; Sawaya GF; Trussell J
    JAMA; 2001 May; 285(17):2232-9. PubMed ID: 11325325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. State-level differences in breast and cervical cancer screening by disability status: United States, 2008.
    Armour BS; Thierry JM; Wolf LA
    Womens Health Issues; 2009; 19(6):406-14. PubMed ID: 19879454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determinants of compliance in a cluster randomised controlled trial on screening of breast and cervix cancer in Mumbai, India. 1. Compliance to screening.
    Dinshaw K; Mishra G; Shastri S; Badwe R; Kerkar R; Ramani S; Thakur M; Uplap P; Kakade A; Gupta S; Ganesh B
    Oncology; 2007; 73(3-4):145-53. PubMed ID: 18408401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extended cycle combined hormonal contraception.
    Steinauer J; Autry AM
    Obstet Gynecol Clin North Am; 2007 Mar; 34(1):43-55, viii. PubMed ID: 17472864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Best practice guidelines for the management of women with epilepsy.
    Crawford P
    Epilepsia; 2005; 46 Suppl 9():117-24. PubMed ID: 16302885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recommendation for and receipt of cancer screenings among medicaid recipients 50 years and older.
    DuBard CA; Schmid D; Yow A; Rogers AB; Lawrence WW
    Arch Intern Med; 2008 Oct; 168(18):2014-21. PubMed ID: 18852404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of breast cancer associated with short-term use of oral contraceptives.
    Folger SG; Marchbanks PA; McDonald JA; Bernstein L; Ursin G; Berlin JA; Daling JR; Norman SA; Strom BL; Weiss LK; Simon MS; Burkman RT; Malone KE; Spirtas R
    Cancer Causes Control; 2007 Mar; 18(2):189-98. PubMed ID: 17216547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The risk of breast, endometrial and ovarian cancer in users of hormonal preparations.
    Bernstein L
    Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):288-96. PubMed ID: 16611204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Both a combined oral contraceptive and depot medroxyprogesterone acetate impair endothelial function in young women.
    Lizarelli PM; Martins WP; Vieira CS; Soares GM; Franceschini SA; Ferriani RA; Patta MC
    Contraception; 2009 Jan; 79(1):35-40. PubMed ID: 19041439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obesity and screening for breast, cervical, and colorectal cancer in women: a review.
    Cohen SS; Palmieri RT; Nyante SJ; Koralek DO; Kim S; Bradshaw P; Olshan AF
    Cancer; 2008 May; 112(9):1892-904. PubMed ID: 18361400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.